Ju-Lun Yang

444 total citations
33 papers, 338 citations indexed

About

Ju-Lun Yang is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Ju-Lun Yang has authored 33 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 18 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in Ju-Lun Yang's work include Virus-based gene therapy research (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and CAR-T cell therapy research (6 papers). Ju-Lun Yang is often cited by papers focused on Virus-based gene therapy research (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and CAR-T cell therapy research (6 papers). Ju-Lun Yang collaborates with scholars based in China and United States. Ju-Lun Yang's co-authors include Qiang Feng, Xinyan Pan, Shuling Song, Wenxing Zhao, Yue Chen, Fang Dai, Tao Li, Lianzhen Li, Baolin Li and Jing Cui and has published in prestigious journals such as PLoS ONE, Experimental Biology and Medicine and BMC Cancer.

In The Last Decade

Ju-Lun Yang

33 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ju-Lun Yang China 12 184 140 99 48 45 33 338
Mónica Vicente-Pascual Spain 10 368 2.0× 125 0.9× 119 1.2× 56 1.2× 38 0.8× 12 510
Rui Tian China 13 290 1.6× 184 1.3× 42 0.4× 16 0.3× 110 2.4× 44 571
Timothy A. Olson United States 9 123 0.7× 62 0.4× 106 1.1× 17 0.4× 91 2.0× 14 446
Pamela Beatty United States 12 197 1.1× 224 1.6× 80 0.8× 50 1.0× 32 0.7× 21 509
Paul Naumann United States 10 118 0.6× 65 0.5× 43 0.4× 22 0.5× 20 0.4× 12 334
Gang Shi China 12 138 0.8× 132 0.9× 52 0.5× 14 0.3× 37 0.8× 21 320
Richard Kirkman United States 11 221 1.2× 46 0.3× 63 0.6× 26 0.5× 46 1.0× 18 379
Marie‐Paule Ducourouble France 12 373 2.0× 165 1.2× 116 1.2× 32 0.7× 29 0.6× 15 571
Marzieh Rezaei Iran 12 155 0.8× 79 0.6× 35 0.4× 24 0.5× 53 1.2× 38 361
Zhihan Wang China 4 171 0.9× 90 0.6× 23 0.2× 18 0.4× 94 2.1× 12 374

Countries citing papers authored by Ju-Lun Yang

Since Specialization
Citations

This map shows the geographic impact of Ju-Lun Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju-Lun Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju-Lun Yang more than expected).

Fields of papers citing papers by Ju-Lun Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ju-Lun Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju-Lun Yang. The network helps show where Ju-Lun Yang may publish in the future.

Co-authorship network of co-authors of Ju-Lun Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Ju-Lun Yang. A scholar is included among the top collaborators of Ju-Lun Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ju-Lun Yang. Ju-Lun Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feng, Qiang, et al.. (2025). KRAS mutation promotes immune escape of lung adenocarcinoma via ZNF24/SLC7A5/PD-L1 axis. BMC Cancer. 25(1). 1417–1417. 1 indexed citations
2.
Wang, Peng, et al.. (2025). KRAS mutations promote PD-L1-mediated immune escape by ETV4 in lung adenocarcinoma. Translational Oncology. 61. 102525–102525. 2 indexed citations
3.
Yang, Ju-Lun, Qiujuan Zhang, Hua Li, & Ming-wei Liu. (2024). Progress Analysis of Personalized Antiplatelet Therapy in Patients with Coronary Heart Disease Undergoing Interventional Therapy. Reviews in Cardiovascular Medicine. 25(12). 462–462. 2 indexed citations
4.
Li, Leilei, Peng Wang, Qiang Feng, et al.. (2022). ZNF24 regulates the progression of KRAS mutant lung adenocarcinoma by promoting SLC7A5 translation. Frontiers in Oncology. 12. 1043177–1043177. 5 indexed citations
5.
Yu, Ting, Xinyan Pan, Qiang Feng, et al.. (2022). BR2 cell penetrating peptide effectively delivers anti-p21Ras scFv to tumor cells with ganglioside expression for therapy of ras-driven tumor. PLoS ONE. 17(6). e0269084–e0269084. 5 indexed citations
6.
7.
8.
Zhou, Xinliang, Qiang Feng, Xinyan Pan, et al.. (2019). CIK cell-based delivery of recombinant adenovirus KGHV500 carrying the anti-p21Ras scFv gene enhances the anti-tumor effect and safety in lung cancer. Journal of Cancer Research and Clinical Oncology. 145(5). 1123–1132. 12 indexed citations
9.
Wang, Mingjuan, Qiang Feng, Xinyan Pan, et al.. (2018). Recombinant Adenovirus KGHV500 and CIK Cells Codeliver Anti-p21-Ras scFv for the Treatment of Gastric Cancer with Wild-Type Ras Overexpression. Molecular Therapy — Oncolytics. 11. 90–101. 9 indexed citations
10.
Bai, Shuang, Qiang Feng, Xinyan Pan, et al.. (2018). Anti-colorectal cancer effects of anti-p21Ras scFv delivered by the recombinant adenovirus KGHV500 and cytokine-induced killer cells. BMC Cancer. 18(1). 1087–1087. 17 indexed citations
11.
Li, Jing, Shuting Jia, Wenru Tang, et al.. (2018). Loss of p21 promoted tumorigenesis in the background of telomere dysfunctions induced by TRF2 and Wrn deficiency. International Journal of Biological Sciences. 14(2). 165–177. 6 indexed citations
12.
Bai, Shuang, Qiang Feng, Xinyan Pan, et al.. (2017). Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer. International Journal of Molecular Medicine. 39(4). 861–868. 13 indexed citations
13.
Pan, Xinyan, Qiang Feng, Yuanyuan Wang, et al.. (2016). [Mutation status of epidermal growth factor receptor and KRAS gene in non-small cell lung cancers at Xuanwei regions of Yunnan Province].. PubMed. 45(4). 226–30. 4 indexed citations
14.
Pan, Xinyan, et al.. (2016). The antitumor efficacy of anti-p21Ras scFv mediated by the dual-promoter-regulated recombinant adenovirus KGHV300. Gene Therapy. 24(1). 40–48. 11 indexed citations
15.
Yang, Ju-Lun, et al.. (2016). A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues. BMC Cancer. 16(1). 131–131. 22 indexed citations
16.
Lei, Jie, Qihua Li, Ju-Lun Yang, et al.. (2015). The antitumor effects of oncolytic adenovirus H101 against lung cancer. International Journal of Oncology. 47(2). 555–562. 27 indexed citations
17.
Zhao, Wenxing, et al.. (2013). Caffeic acid phenethyl ester attenuates pro-inflammatory and fibrogenic phenotypes of LPS-stimulated hepatic stellate cells through the inhibition of NF-κB signaling. International Journal of Molecular Medicine. 33(3). 687–694. 33 indexed citations
18.
Chen, Yue, Hong Zou, Liying Yang, et al.. (2012). ER81-shRNA Inhibits Growth of Triple-negative Human Breast Cancer Cell Line MDA-MB-231 In Vivo and in Vitro. Asian Pacific Journal of Cancer Prevention. 13(5). 2385–2392. 6 indexed citations
19.
Yang, Ju-Lun, Yan Ren, Li Wang, et al.. (2010). PTEN mutation spectrum in breast cancers and breast hyperplasia. Journal of Cancer Research and Clinical Oncology. 136(9). 1303–1311. 41 indexed citations
20.
Yang, Ju-Lun, et al.. (2009). NOEY2 mutations in primary breast cancers and breast hyperplasia. The Breast. 18(3). 197–203. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mónica Vicente-Pascual Breakdown of academic impact, for papers by Rui Tian Breakdown of academic impact, for papers by Timothy A. Olson Breakdown of academic impact, for papers by Pamela Beatty Breakdown of academic impact, for papers by Paul Naumann Breakdown of academic impact, for papers by Gang Shi Breakdown of academic impact, for papers by Richard Kirkman Breakdown of academic impact, for papers by Marie‐Paule Ducourouble Breakdown of academic impact, for papers by Marzieh Rezaei Breakdown of academic impact, for papers by Zhihan Wang
Rankless by CCL
2026